Search results for "Highlights"


 
Results 11 - 20 of about 108 for "Highlights".

Antidepressants and psychological therapies reduce IBS symptoms, meta-analysis finds

Psychological therapies were effective for irritable bowel syndrome (IBS) when delivered in person, whereas therapy that was self-administered, internet-based, or provided with minimal contact did not yield significant benefit.
September 2018

Highlights

The prevalence of any suspected liver fibrosis in patients with diabetes was 21% in a recent study, leading the authors to call for more aggressive screening in patients with obesity and diabetes.
January 2021

Highlights

About 84% of participants randomly assigned to receive rifabutin in addition to amoxicillin and omeprazole achieved Helicobacter pylori eradication, compared to 58% of those who received amoxicillin and omeprazole alone.
May 2020

Highlights

Thirty-day mortality was slightly lower among high-risk patients who underwent endoscopy for an acute upper GI bleed within 24 hours of a consult instead of within six hours, although the difference was not statistically significant.
April 2020

Highlights

While NSAIDs and a high consumption of fruits and vegetables were associated with a decreased incidence of colorectal cancer, frequent consumption of alcohol or meat was linked to increased colorectal cancer incidence, a systematic review found.
October 2020

Efficacy, safety of second-line therapies analyzed for two types of IBS

A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
April 2019

Beta-blockers linked to better outcomes in some patients with cirrhosis

Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
April 2019

Keeping tabs

Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the
November 2020

Probiotics reduce C. difficile in hospitalized patients on antibiotics, review finds

In 19 randomized controlled trials of 6,261 hospitalized patients on antibiotics, the incidence of C. difficile was 1.6% among patients taking probiotics compared to 3.9% in controls.
February 2017

Highlights

A retrospective cohort study compared amoxicillin-clavulanate with metronidazole-fluoroquinolone and found no differences in outcomes including risks for inpatient admission or surgery, while Clostridioides difficile risk appeared higher in older
February 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next